Integrative Cancer Therapies投稿须知

期刊简介

《Integrative Cancer Therapies》是由SAGE Publications Inc.出版社于2002年创办的英文国际期刊（ISSN: 1534-7354，E-ISSN: 1552-695X），该期刊长期致力于全科医学与补充医学领域的创新研究，主要研究方向为医学-全科医学与补充医学。作为SCIE收录期刊（JCR分区 Q2，中科院 3区），本刊采用OA开放获取模式（OA占比1%），以发表全科医学与补充医学领域等方向的原创性研究为核心（研究类文章占比80.00%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在90篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Integrative Cancer Therapies审稿周期约为 12周，或约稿。该刊近年未被列入国际预警名单，年发文量约90篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
90 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 3区	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学 ONCOLOGY 肿瘤学 3区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 3区	INTEGRATIVE & COMPLEMENTARY MEDICINE 全科医学与补充医学 ONCOLOGY 肿瘤学 3区 4区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：INTEGRATIVE & COMPLEMENTARY MEDICINE	SCIE	Q2	13 / 43	70.9%
学科：ONCOLOGY	SCIE	Q2	151 / 322	53.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：INTEGRATIVE & COMPLEMENTARY MEDICINE	SCIE	Q2	19 / 43	56.98%
学科：ONCOLOGY	SCIE	Q3	164 / 322	49.22%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：4.8

SJR：0.687

SNIP：0.757

学科类别	分区	排名	百分位
大类：Medicine 小类：Complementary and Alternative Medicine	Q1	25 / 105	76%
大类：Medicine 小类：Oncology	Q2	178 / 404	56%

期刊发文

Aidi Injection, a Traditional Chinese Medicine Injection, Could Be Used as an Adjuvant Drug to Improve Quality of Life of Cancer Patients Receiving Chemotherapy: A Propensity Score Matching Analysis.
Author: Xie G¹, Cui Z¹, Peng K¹, Zhou X¹, Xia Q^2,³, Xu D^1,^2,³.

Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418810799. doi: 10.1177/1534735418810799. Epub 2018 Nov 27.
Shenqi Fuzheng Injection in the Treatment of Breast Cancer: A Meta-analysis of Randomized Controlled Trials.
Author: Liu S¹, Zhang D¹, Wu J¹, Wang K¹, Zhao Y¹, Ni M¹, Meng Z¹, Zhang X¹.

Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418816824. doi: 10.1177/1534735418816824. Epub 2018 Dec 4.
Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Author: Liu Y¹, May BH², Zhang AL², Guo X¹, Lu C¹, Xue CC^1,², Zhang H¹.

Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418817833. doi: 10.1177/1534735418817833. Epub 2018 Dec 10.
A Purified Resin Glycoside Fraction from Pharbitidis Semen Induces Paraptosis by Activating Chloride Intracellular Channel-1 in Human Colon Cancer Cells.
Author: Zhu D¹, Chen C¹, Xia Y¹, Kong LY¹, Luo J¹.

Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418822120. doi: 10.1177/1534735418822120. Epub 2019 Jan 7.
Effects of Shen Cao Granules on Chemotherapy-Induced Thrombocytopenia in Gastrointestinal Cancer Patients: A Randomized Controlled Trial.
Author: Yu C¹, Liu W¹, Mu Y¹, Hou A¹, Li Y¹.

Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419829568. doi: 10.1177/1534735419829568.
Combination of Astragali Polysaccharide and Curcumin Improves the Morphological Structure of Tumor Vessels and Induces Tumor Vascular Normalization to Inhibit the Growth of Hepatocellular Carcinoma.
Author: Tang D¹, Zhang S², Shi X¹, Wu J¹, Yin G¹, Tan X³, Liu F¹, Wu X¹, Du X¹.

Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735418824408. doi: 10.1177/1534735418824408.
Meta-Analysis of 5-Fluorouracil-Based Chemotherapy Combined With Traditional Chinese Medicines for Colorectal Cancer Treatment.
Author: Chen P^1,², Ni W², Xie T^1,², Sui X².

Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419828824. doi: 10.1177/1534735419828824.
Network Meta-Analysis of Chinese Herbal Injections Plus the FOLFOX Regimen for the Treatment of Colorectal Cancer in China.
Author: Zhang D¹, Wu J¹, Duan X¹, Wang K¹, Ni M¹, Liu S¹, Zhang X¹, Zhang B¹, Zhao Y¹.

Journal: Integr Cancer Ther. 2019 Jan-Dec;18:1534735419827098. doi: 10.1177/1534735419827098.

Integrative Cancer Therapies

综合癌症治疗

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询